Metagenomi Therapeutics, Inc. (MGX) AI Dilution Summary

Cash was $120,664,000 at 2026-06-30, against estimated monthly burn of $6,504,333. The company's funding channel is an at-the-market program with Jefferies LLC, authorised to $75,000,000, with $0 sold to date. Dilution here is driven primarily by that ATM program.